Overview

Mitigating Delirium With Fluvoxamine Treatment for Non-Cardiac Surgery

Status:
NOT_YET_RECRUITING
Trial end date:
2028-04-01
Target enrollment:
Participant gender:
Summary
The investigation will establish biological plausibility and infrastructure required for a multisite clinical trial evaluating the re-purposing of fluvoxamine to mitigate postoperative delirium risk in geriatric patients undergoing non-cardiac non-intracranial surgery.
Phase:
PHASE3
Details
Lead Sponsor:
Washington University School of Medicine
Collaborator:
National Institute on Aging (NIA)
Treatments:
Fluvoxamine
microcrystalline cellulose